XTalks

JULY 13, 2022

has provided an easy way to provide patients and clinicians with potentially life-saving information,” said George Bakris, MD, Director of the Comprehensive Hypertension Center, University of Chicago and the American Diabetes Association, in Healthy.io’s press release. An ACR urine reagent dipstick/strip. Healthy.io Healthy.io

Reagent 98

Reagent In-Vitro Radiology Life Science 98

XTalks

JUNE 27, 2022

CerTest Biotec specializes in the development and manufacturing of in vitro diagnostic medical devices and has expertise in the detection of human diseases. In a joint press release , the companies said the aim of the partnership is to design a diagnostic test that can help advance understanding of the global spread of the disease.

Development 83

Development In-Vitro Reagent Vaccination 83

pharmaphorum

SEPTEMBER 29, 2022

She is the Co-Chair of the firm’s Health Care Practice Group, Co-Chair, Health Care & Life Sciences Sector – Medical Devices, and a core member of the firm’s life sciences and telemedicine industry teams. In Part 1 of this series, general wellness devices and mobile medical applications (MMAs) will be considered.

Development 104

Development Regulation Production Life Science 104

XTalks

APRIL 22, 2022

Both the areas of drug development and clinical trials are increasingly using in vitro assays to help determine the efficacy of an investigational therapeutic. Flow cytometric receptor occupancy assays are being increasingly used in preclinical and clinical studies. What is Flow Cytometry?

Clinical Trials 98

Clinical Trials Clinical Trials Trials Antibody 98

XTalks

OCTOBER 1, 2020

A life-changing moment came for Dr. Leaving academia for industry is a route that academic scientists and professors did not traditionally pursue in the past due to perceived differences in skillsets, experiences and even associated stigmas. The journey first starts with the decision to make the switch. Key Moments.

Scientist 52

Scientist In-Vitro Research Life Science 52

XTalks

JANUARY 6, 2025

In recent years, CRISPR has also been effectively applied to reduce or eliminate persistent viral infections in vitro and in animal models, raising hope for its use in treating latent and chronic viral infections. Related: Biotech IPOs in 2024: Navigating the New Wave of Innovation 1.

Gene Therapy 111

Gene Therapy RNA Gene Editing Gene 111